About: Resveratrol attenuates lipopolysaccharide-induced hepatitis in D-Galactosamine sensitized rats: Role of nitric oxide synthase 2 and heme oxygenase-1

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Resveratrol attenuates lipopolysaccharide-induced hepatitis in D-Galactosamine sensitized rats: Role of nitric oxide synthase 2 and heme oxygenase-1 Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Resveratrol improves hepatotoxic markers and morphology after the hepatic insult. Among the mechanisms responsible for the hepatoprotective effects of resveratrol are reduction of NO production, downeregulation of nitric oxide synthese, madification of oxidative stress parameters and modulation of heme oxygenase-1. Resveratrol improves hepatotoxic markers and morphology after the hepatic insult. Among the mechanisms responsible for the hepatoprotective effects of resveratrol are reduction of NO production, downeregulation of nitric oxide synthese, madification of oxidative stress parameters and modulation of heme oxygenase-1. (en)
Title	Resveratrol attenuates lipopolysaccharide-induced hepatitis in D-Galactosamine sensitized rats: Role of nitric oxide synthase 2 and heme oxygenase-1 Resveratrol attenuates lipopolysaccharide-induced hepatitis in D-Galactosamine sensitized rats: Role of nitric oxide synthase 2 and heme oxygenase-1 (en)
skos:prefLabel	Resveratrol attenuates lipopolysaccharide-induced hepatitis in D-Galactosamine sensitized rats: Role of nitric oxide synthase 2 and heme oxygenase-1 Resveratrol attenuates lipopolysaccharide-induced hepatitis in D-Galactosamine sensitized rats: Role of nitric oxide synthase 2 and heme oxygenase-1 (en)
skos:notation	RIV/68378041:_____/09:00330496!RIV10-AV0-68378041
http://linked.open...avai/riv/aktivita	P Z
http://linked.open...avai/riv/aktivity	P(GA305/07/0061), P(GA305/09/0004), P(NR9379), Z(AV0Z50390512), Z(MSM0021620807)
http://linked.open...iv/cisloPeriodika	3-4
http://linked.open...vai/riv/dodaniDat	2010
http://linked.open...aciTvurceVysledku	Zídek, Zdeněk Kmoníčková, Eva
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Ústav experimentální medicíny AV ČR, v. v. i.
http://linked.open...dnocenehoVysledku	339225
http://linked.open...ai/riv/idVysledku	RIV/68378041:_____/09:00330496
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	resveratrol; lipopolysacchride; nitrix oxide (en)
http://linked.open.../riv/klicoveSlovo	lipopolysacchride resveratrol nitrix oxide
http://linked.open...odStatuVydavatele	NL - Nizozemsko
http://linked.open...ontrolniKodProRIV	[822CEBD7E43C]
http://linked.open...i/riv/nazevZdroje	Nitric Oxide-Biology and Chemistry
http://linked.open...in/vavai/riv/obor	FR
http://linked.open...ichTvurcuVysledku	2 (xsd:int)
http://linked.open...cetTvurcuVysledku	7 (xsd:int)
http://linked.open...vavai/riv/projekt	Immunopharmacological potential of endoplasmic Ca(2+)-ATPase (SERCA) inhibitors Pharmacological implications of the interplay between inducible heme oxygenase/carbon monoxide and nitric oxide synthase/nitric oxide systems in liver Critical assessment of some current natural products with potential therapeutic applications in liver injuries: in vivo and in vitro evaluation
http://linked.open...UplatneniVysledku	2009
http://linked.open...v/svazekPeriodika	21
http://linked.open...iv/tvurceVysledku	Martínek, J. Zídek, Zdeněk Farghali, H. Hořínek, A. Kameníková, L. Kmoníčková, Eva Černý, D.
http://linked.open...ain/vavai/riv/wos	000272267600010
http://linked.open...n/vavai/riv/zamer	Metabolické, endokrinní a genetické aspekty prevence, diagnostiky a terapie kardiovaskulárních, cerebrovaskulárních a renovaskulárních onemocnění Molekulární, buněčné a systémové mechanizmy závažných onemocnění lidského organizmu, jejich diagnostika, terapie a farmakoterapie
issn	1089-8603
number of pages	10 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software